The effect of vaginal administration of a PgE1 analogue to terminate missed abortion and fetal death in utero was evaluated in 62 women with gestation ranging from the 13th to the 37th week. Abortion occurred in 85.4% of women with missed abortion and in 86% of women with fetal death. In both groups, the mean induction time was less than 12 h. The incidence of side effects, primarily gastrointestinal symptoms, was infrequent.
THE USE OF 16,16-DIMETHYL-TRANS-DELTA-2 PROSTAGLANDIN-E1 METHYL-ESTER VAGINAL SUPPOSITORIES FOR MANAGEMENT OF MISSED ABORTION AND FETAL DEATH / Fruzzetti, F; Melis, Gb; Dececco, L; Genazzani, Andrea Riccardo; Fioretti, P.. - In: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. - ISSN 0020-7292. - STAMPA. - 36:(1991), pp. 115-119.
THE USE OF 16,16-DIMETHYL-TRANS-DELTA-2 PROSTAGLANDIN-E1 METHYL-ESTER VAGINAL SUPPOSITORIES FOR MANAGEMENT OF MISSED ABORTION AND FETAL DEATH
GENAZZANI, Andrea Riccardo;
1991
Abstract
The effect of vaginal administration of a PgE1 analogue to terminate missed abortion and fetal death in utero was evaluated in 62 women with gestation ranging from the 13th to the 37th week. Abortion occurred in 85.4% of women with missed abortion and in 86% of women with fetal death. In both groups, the mean induction time was less than 12 h. The incidence of side effects, primarily gastrointestinal symptoms, was infrequent.
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
